☰

Rachel J. Bergerson, Ph.D. - Publications

Affiliations: 
2010 Microbiology, Immunology and Cancer Biology University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Molecular Biology, Genetics, Oncology
Tree Info Similar researchers PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Sachs K, Sarver AL, Noble-Orcutt KE, LaRue RS, Antony ML, Chang D, Lee Y, Navis CM, Hillesheim AL, Nykaza IR, Ha NA, Hansen CJ, Karadag FK, Bergerson RJ, Verneris MR, et al. Single-cell gene expression analyses reveal distinct self-renewing and proliferating subsets in the leukemia stem cell compartment in acute myeloid leukemia. Cancer Research. PMID 31784425 DOI: 10.1158/0008-5472.Can-18-2932  0.588
2018 Pilbeam K, Wang H, Taras E, Bergerson RJ, Ettestad B, DeFor T, Borgatti A, Vallera DA, Verneris MR. Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors. Oncotarget. 9: 11938-11947. PMID 29552283 DOI: 10.18632/Oncotarget.21187  0.314
2016 Bergerson RJ, Williams R, Wang H, Shanley R, Colbenson G, Kerber A, Cooley S, Curtsinger J, Felices M, Miller JS, Verneris MR. Fewer Circulating Natural Killer Cells 28 Days After Double Cord Blood Transplantation Predicts Inferior Survival and IL-15 Response. Blood Advances. 1: 208-218. PMID 29188237 DOI: 10.1182/Bloodadvances.2016000158  0.312
2016 Stoddart A, Qian Z, Fernald AA, Bergerson RJ, Wang J, Karrison T, Anastasi J, Bartom ET, Sarver AL, McNerney ME, Largaespada DA, Le Beau MM. Retroviral insertional mutagenesis identifies the del(5q) genes, CXXC5, TIFAB and ETF1, as well as the Wnt pathway, as potential targets in del(5q) myeloid neoplasms. Haematologica. PMID 26944478 DOI: 10.3324/Haematol.2015.139527  0.559
2016 Knorr DA, Wang H, Aurora M, MacMillan ML, Holton SG, Bergerson R, Cao Q, Weisdorf DJ, Cooley S, Brunstein C, Miller JS, Wagner JE, Blazar BR, Verneris MR. Loss of T Follicular Helper Cells In the Peripheral Blood Of Patients With Chronic Graft vs. Host Disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26806586 DOI: 10.1016/J.Bbmt.2016.01.003  0.35
2015 Abu Shanap MS, Cooley S, Luo X, Qing C, Curtsinger J, Bergerson R, Bejanyan N, Stefanski H, Brunstein C, Weisdorf DJ, Blazar BR, Miller JS, Wagner JE, Verneris MR. Defining Successful Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (HCT) Blood. 126: 1934-1934. DOI: 10.1182/Blood.V126.23.1934.1934  0.336
2013 Stoddart A, Fernald A, Bergerson RJ, Wang J, McNerney ME, Karrison T, Anastasi J, Bartom E, Sarver AG, Qian Z, Wolff L, Largaespada DA, Beau MMl. Retroviral Insertional Mutagenesis In Egr1+/- mice, Haploinsufficient For a Human Del(5q) Myeloid Leukemia Gene, Develop Myeloid Neoplasms With Proviral Insertions In Genes Syntenic To Human 5q Blood. 122: 1275-1275. DOI: 10.1182/Blood.V122.21.1275.1275  0.677
2012 Bergerson RJ, Collier LS, Sarver AL, Been RA, Lugthart S, Diers MD, Zuber J, Rappaport AR, Nixon MJ, Silverstein KA, Fan D, Lamblin AF, Wolff L, Kersey JH, Delwel R, et al. An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model. Blood. 119: 4512-23. PMID 22427200 DOI: 10.1182/Blood-2010-04-281428  0.608
2011 Stoddart A, McNerney ME, Bartom E, Bergerson R, Young DJ, Qian Z, Wang J, Fernald AA, Davis EM, Larson RA, White KP, Le Beau MM. Genetic pathways leading to therapy-related myeloid neoplasms. Mediterranean Journal of Hematology and Infectious Diseases. 3: e2011019. PMID 21713073 DOI: 10.4084/Mjhid.2011.019  0.389
2011 Wiesner SM, Geurts JL, Diers MD, Bergerson RJ, Hasz DE, Morgan KJ, Largaespada DA. Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype. American Journal of Hematology. 86: 579-85. PMID 21681782 DOI: 10.1002/Ajh.22035  0.655
2009 Bergerson RJ, Collier LS, Lugthart S, Allaei R, Nixon MJ, Silverstein KA, Sarver A, Fan DF, Lamblin AJ, Wolff L, Kersey JH, O'Sullivan MG, Delwel R, Kogan SC, Adams DJ, et al. An Insertional Mutagenesis Screen for Genes That Cooperate with Mll-AF9 in Leukemogenesis. Blood. 114: 3962-3962. DOI: 10.1182/Blood.V114.22.3962.3962  0.704
2009 Poiré X, Diaz-Flores E, Bergerson RJ, Sher D, Odenike O, Shannon K, Largaespada D, Stock W. Combinations of Kinase Inhibitors May Be An Effective Therapeutic Strategy for Acute Myeloid Leukemia (AML) with MLL-AF9 Expression. Blood. 114: 1032-1032. DOI: 10.1182/Blood.V114.22.1032.1032  0.535
2008 Bergerson RJ, Largaespada DA. What gene have I ID'ed? Blood. 111: 417-472. DOI: 10.1182/Blood-2007-10-118067  0.636
2007 Bergerson RJ, Collier LS, Allaei R, Silverstein KA, Lamblin AF, Wolff L, Kogan SC, Kersey JH, Adams DJ, Largaespada DA. Novel Mll-AF9 Cooperating Genes Identified in a Leukemogenesis Screen Using Retroviral Mutagenesis. Blood. 110: 825-825. DOI: 10.1182/Blood.V110.11.825.825  0.695
2006 Bergerson RJ, Collier LS, Cox T, Hudson WA, Allaei R, Wolff L, Kersey JH, Adams DJ, Largaespada DA. A Screen for Mll-AF9 Cooperating Mutations in Leukemogenesis Using MLV-Based Mutagenesis. Blood. 108: 1417-1417. DOI: 10.1182/Blood.V108.11.1417.1417  0.649
Show low-probability matches.